-
1
-
-
0033680583
-
P2 purinergic receptors: modulation of cell function and therapeutic potential
-
Burnstock G, Williams M (2000) P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 295: 862-869.
-
(2000)
J Pharmacol Exp Ther
, vol.295
, pp. 862-869
-
-
Burnstock, G.1
Williams, M.2
-
2
-
-
0037304906
-
14 receptor) adds diversity to the P2Y receptor family
-
14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24: 52-55.
-
(2003)
Trends Pharmacol Sci
, vol.24
, pp. 52-55
-
-
Abbracchio, M.P.1
Boeynaems, J.M.2
Barnard, E.A.3
Boyer, J.L.4
Kennedy, C.5
Miras-Portugal, M.T.6
King, B.F.7
Gachet, C.8
Jacobson, K.A.9
Weisman, G.A.10
Burnstock, G.11
-
3
-
-
0036788971
-
Molecular physiology of P2X receptors
-
North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067.
-
(2002)
Physiol Rev
, vol.82
, pp. 1013-1067
-
-
North, R.A.1
-
4
-
-
0037068428
-
Purine and pyrimidine (P2) receptors as drug targets
-
Jacobson KA, Jarvis MF, Williams M (2002) Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 45: 4057-4093.
-
(2002)
J Med Chem
, vol.45
, pp. 4057-4093
-
-
Jacobson, K.A.1
Jarvis, M.F.2
Williams, M.3
-
5
-
-
60449116653
-
Development of selective agonists and antagonists of P2Y receptors
-
Jacobson KA, Ivanov AA, de Castro S, Harden TK, Ko H (2009) Development of selective agonists and antagonists of P2Y receptors. Purinergic Signal 5: 75-89.
-
(2009)
Purinergic Signal
, vol.5
, pp. 75-89
-
-
Jacobson, K.A.1
Ivanov, A.A.2
de Castro, S.3
Harden, T.K.4
Ko, H.5
-
6
-
-
77954308978
-
P2Y nucleotide receptors; promise of therapeutic applications
-
Jacobson KA, Boeynaems JM (2010) P2Y nucleotide receptors; promise of therapeutic applications. Drug Discov Today 15: 570-578.
-
(2010)
Drug Discov Today
, vol.15
, pp. 570-578
-
-
Jacobson, K.A.1
Boeynaems, J.M.2
-
7
-
-
0026684355
-
PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses
-
Lambrecht G, Friebe T, Grimm U, Windscheif U, Bungardt E, Hildebrandt C, Baumert HG, Spatz-Kumbel G, Mutschler E (1992) PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur J Pharmacol 217: 217-219.
-
(1992)
Eur J Pharmacol
, vol.217
, pp. 217-219
-
-
Lambrecht, G.1
Friebe, T.2
Grimm, U.3
Windscheif, U.4
Bungardt, E.5
Hildebrandt, C.6
Baumert, H.G.7
Spatz-Kumbel, G.8
Mutschler, E.9
-
8
-
-
0032424086
-
Synthesis and structure activity relationships of pyridoxal-6-arylazo-5'-phosphate and phosphonate derivatives as P2 receptor antagonists
-
Kim YC, Camaioni E, Ziganshin AU, Ji XJ, King BF, Wildman SS, Rychkov A, Yoburn J, Kim H, Mohanram A, Harden TK, Boyer JL, Burnstock G, Jacobson KA (1998) Synthesis and structure activity relationships of pyridoxal-6-arylazo-5'-phosphate and phosphonate derivatives as P2 receptor antagonists. Drug Dev Res 45: 52-66.
-
(1998)
Drug Dev Res
, vol.45
, pp. 52-66
-
-
Kim, Y.C.1
Camaioni, E.2
Ziganshin, A.U.3
Ji, X.J.4
King, B.F.5
Wildman, S.S.6
Rychkov, A.7
Yoburn, J.8
Kim, H.9
Mohanram, A.10
Harden, T.K.11
Boyer, J.L.12
Burnstock, G.13
Jacobson, K.A.14
-
9
-
-
30444453661
-
The glutamate story
-
Watkins JC, Jane DE (2006) The glutamate story. Br J Pharmacol 147(Suppl 1): S100-S108.
-
(2006)
Br J Pharmacol
, vol.147
, Issue.SUPPL. 1
-
-
Watkins, J.C.1
Jane, D.E.2
-
11
-
-
84856253130
-
-
Tocris Bioscience webpage for purinergic (P2X) receptors Accessed 1 June 2011
-
Tocris Bioscience webpage for purinergic (P2X) receptors (2011). http://www. tocris. com/pharmacologicalBrowser. php?ItemId=5081. Accessed 1 June 2011.
-
(2011)
-
-
-
12
-
-
84856254390
-
-
Tocris Bioscience webpage for purinergic (P2Y) receptors Accessed 1 June 2011
-
Tocris Bioscience webpage for purinergic (P2Y) receptors (2011). http://www. tocris. com/pharmacologicalBrowser. php?ItemId=187653. Accessed 1 June 2011.
-
(2011)
-
-
-
13
-
-
0033955313
-
1 receptors
-
1 receptors. Eur J Pharmacol 387: R19-R21.
-
(2000)
Eur J Pharmacol
, vol.387
-
-
Lambrecht, G.1
Rettinger, J.2
Bäumert, H.G.3
Czeche, S.4
Damer, S.5
Ganso, M.6
Hildebrandt, C.7
Niebel, B.8
Spatz-Kümbel, G.9
Schmalzing, G.10
Mutschler, E.11
-
15
-
-
0029658866
-
P2-purinoceptor antagonists. III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin
-
Bültmann R, Wittenburg H, Pause B, Kurz G, Nickel P, Starke K (1996) P2-purinoceptor antagonists. III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin. Naunyn Schmiedebergs Arch Pharmacol 354: 498-504.
-
(1996)
Naunyn Schmiedebergs Arch Pharmacol
, vol.354
, pp. 498-504
-
-
Bültmann, R.1
Wittenburg, H.2
Pause, B.3
Kurz, G.4
Nickel, P.5
Starke, K.6
-
16
-
-
0032577682
-
NF279: a novel potent and selective antagonist of P2X receptor-mediated responses
-
Damer S, Niebel B, Czeche S, Nickel P, Ardanuy U, Schmalzing G, Rettinger J, Mutschler E, Lambrecht G (1998) NF279: a novel potent and selective antagonist of P2X receptor-mediated responses. Eur J Pharmacol 350: R5-R6.
-
(1998)
Eur J Pharmacol
, vol.350
-
-
Damer, S.1
Niebel, B.2
Czeche, S.3
Nickel, P.4
Ardanuy, U.5
Schmalzing, G.6
Rettinger, J.7
Mutschler, E.8
Lambrecht, G.9
-
21
-
-
33745146902
-
The suramin analog 4,4′,4″,4″′-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups
-
Hausmann R, Rettinger J, Gerevich Z, Meis S, Kassack M, Illes P, Lambrecht G, Schmalzing G (2006) The suramin analog 4, 4′, 4″, 4″′-(carbonylbis(imino-5, 1, 3-benzenetriylbis(carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups. Mol Pharmacol 69: 2058-2067.
-
(2006)
Mol Pharmacol
, vol.69
, pp. 2058-2067
-
-
Hausmann, R.1
Rettinger, J.2
Gerevich, Z.3
Meis, S.4
Kassack, M.5
Illes, P.6
Lambrecht, G.7
Schmalzing, G.8
-
22
-
-
27444436716
-
11 receptor antagonists with nanomolar potency
-
11 receptor antagonists with nanomolar potency. J Med Chem 48: 7040-7048.
-
(2005)
J Med Chem
, vol.48
, pp. 7040-7048
-
-
Ullmann, H.1
Meis, S.2
Hongwiset, D.3
Marzian, C.4
Wiese, M.5
Nickel, P.6
Communi, D.7
Boeynaems, J.M.8
Wolf, C.9
Hausman, R.10
Schmalzing, G.11
Kassack, M.12
-
23
-
-
73949115258
-
11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells
-
11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells. J Pharmacol Exp Ther 332: 238-247.
-
(2010)
J Pharmacol Exp Ther
, vol.332
, pp. 238-247
-
-
Meis, S.1
Hamacher, A.2
Hongwiset, D.3
Marzian, C.4
Wiese, M.5
Eckstein, N.6
Royer, H.D.7
Communi, D.8
Boeynaems, J.M.9
Hausmann, R.10
Schmalzing, R.11
Kassack, M.U.12
-
29
-
-
0035107660
-
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits
-
Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Séguéla P, Voigt M, Humphrey PP (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53: 107-118.
-
(2001)
Pharmacol Rev
, vol.53
, pp. 107-118
-
-
Khakh, B.S.1
Burnstock, G.2
Kennedy, C.3
King, B.F.4
North, R.A.5
Séguéla, P.6
Voigt, M.7
Humphrey, P.P.8
-
32
-
-
0034624785
-
1 receptor ligands
-
1 receptor ligands. J Med Chem 43: 829-842.
-
(2000)
J Med Chem
, vol.43
, pp. 829-842
-
-
Nandanan, E.1
Jang, S.Y.2
Moro, S.3
Kim, H.O.4
Siddiqui, M.A.5
Russ, P.6
Marquez, V.E.7
Busson, R.8
Herdewijn, P.9
Harden, T.K.10
Boyer, J.L.11
Jacobson, K.A.12
-
33
-
-
0242267908
-
1 receptor antagonists
-
1 receptor antagonists. J Med Chem 46: 4974-4987.
-
(2003)
J Med Chem
, vol.46
, pp. 4974-4987
-
-
Kim, H.S.1
Ohno, M.2
Xu, B.3
Kim, H.O.4
Choi, Y.5
Ji, X.D.6
Maddileti, S.7
Marquez, V.E.8
Harden, T.K.9
Jacobson, K.A.10
-
36
-
-
33748572631
-
6 receptor
-
6 receptor. J Med Chem 49: 5532-5543.
-
(2006)
J Med Chem
, vol.49
, pp. 5532-5543
-
-
Besada, P.1
Shin, D.H.2
Costanzi, S.3
Ko, H.4
Mathe, C.5
Gagneron, J.6
Gosselin, G.7
Maddileti, S.8
Harden, T.K.9
Jacobson, K.A.10
-
38
-
-
77249142404
-
The art of the chemical probe
-
Frye SV (2010) The art of the chemical probe. Nat Chem Biol 6: 159-161.
-
(2010)
Nat Chem Biol
, vol.6
, pp. 159-161
-
-
Frye, S.V.1
-
39
-
-
77953722717
-
Probing the probes: fitness factors for small molecule tools
-
Workman P, Collins I (2010) Probing the probes: fitness factors for small molecule tools. Chem Biol 17: 561-577.
-
(2010)
Chem Biol
, vol.17
, pp. 561-577
-
-
Workman, P.1
Collins, I.2
-
40
-
-
58149392612
-
Suramin: clinical uses and structure-activity relationships
-
McGeary RP, Bennett AJ, Tran QB, Cosgrove KL, Ross BP (2008) Suramin: clinical uses and structure-activity relationships. Mini Rev Med Chem 8: 1384-1394.
-
(2008)
Mini Rev Med Chem
, vol.8
, pp. 1384-1394
-
-
McGeary, R.P.1
Bennett, A.J.2
Tran, Q.B.3
Cosgrove, K.L.4
Ross, B.P.5
-
42
-
-
38749115790
-
Painful purinergic receptors
-
Donnelly-Roberts D, McGaraughy S, Shieh CC, Honore P, Jarvis MF (2008) Painful purinergic receptors. J Pharmacol Exp Ther 324: 409-415.
-
(2008)
J Pharmacol Exp Ther
, vol.324
, pp. 409-415
-
-
Donnelly-Roberts, D.1
McGaraughy, S.2
Shieh, C.C.3
Honore, P.4
Jarvis, M.F.5
-
45
-
-
34347333404
-
7 receptor function and indicates a role in chronic pain states
-
7 receptor function and indicates a role in chronic pain states. Br J Pharmacol 151: 571-579.
-
(2007)
Br J Pharmacol
, vol.151
, pp. 571-579
-
-
Donnelly-Roberts, D.L.1
Jarvis, M.F.2
-
46
-
-
20144375454
-
7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
-
7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114: 386-396.
-
(2005)
Pain
, vol.114
, pp. 386-396
-
-
Chessell, I.P.1
Hatcher, J.P.2
Bountra, C.3
Michel, A.D.4
Hughes, J.P.5
Green, P.6
Egerton, J.7
Murfin, M.8
Richardson, J.9
Peck, W.L.10
Grahames, C.B.11
Casula, M.A.12
Yiangou, Y.13
Birch, R.14
Anand, P.15
Buell, G.N.16
-
47
-
-
76149099290
-
7 purinergic receptor: from physiology to neurological disorders
-
7 purinergic receptor: from physiology to neurological disorders. FASEB J 24: 337-345.
-
(2010)
FASEB J
, vol.24
, pp. 337-345
-
-
Skaper, S.D.1
Debetto, P.2
Giusti, P.3
-
48
-
-
77955171038
-
Emerging structures and ligands for P2X3 and P2X4 receptors-towards novel treatments of neuropathic pain
-
Müller CE (2010) Emerging structures and ligands for P2X3 and P2X4 receptors-towards novel treatments of neuropathic pain. Purinergic Signal 6: 145-148.
-
(2010)
Purinergic Signal
, vol.6
, pp. 145-148
-
-
Müller, C.E.1
-
49
-
-
33745142545
-
7 antagonists
-
7 antagonists. J Med Chem 49: 3659-3666.
-
(2006)
J Med Chem
, vol.49
, pp. 3659-3666
-
-
Nelson, D.W.1
Gregg, R.J.2
Kort, M.E.3
Perez-Medrano, A.4
Voight, E.A.5
Wang, Y.6
Grayson, G.7
Namovic, M.T.8
Donelly-Roberts, D.L.9
Niforatos, W.10
Honore, P.11
Jarvis, M.F.12
Faltynek, C.R.13
Carroll, W.A.14
-
50
-
-
67849099111
-
The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice
-
Honore P, Donnelly-Roberts D, Namovic M, Zhong C, Wade C, Chandran P, Zhu C, Carroll W, Perez-Medrano A, Iwakura Y, Jarvis MF (2009) The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice. Behav Brain Res 204: 77-81.
-
(2009)
Behav Brain Res
, vol.204
, pp. 77-81
-
-
Honore, P.1
Donnelly-Roberts, D.2
Namovic, M.3
Zhong, C.4
Wade, C.5
Chandran, P.6
Zhu, C.7
Carroll, W.8
Perez-Medrano, A.9
Iwakura, Y.10
Jarvis, M.F.11
-
52
-
-
54949134401
-
7 receptor that contribute to human and rat species differences in antagonist effects
-
7 receptor that contribute to human and rat species differences in antagonist effects. Br J Pharmacol 155: 738-751.
-
(2008)
Br J Pharmacol
, vol.155
, pp. 738-751
-
-
Michel, A.D.1
Clay, W.C.2
Ng, S.W.3
Roman, S.4
Thompson, K.5
Condreay, J.P.6
Hall, M.7
Holbrook, J.8
Livermore, D.9
Senger, S.10
-
54
-
-
33751165071
-
7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat
-
7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 319: 1376-1385.
-
(2006)
J Pharmacol Exp Ther
, vol.319
, pp. 1376-1385
-
-
Honore, P.1
Donnelly-Roberts, D.2
Namovic, M.T.3
Hsieh, G.4
Zhu, C.Z.5
Mikusa, J.P.6
Hernandez, G.7
Zhong, C.8
Gauvin, D.M.9
Chandran, P.10
Harris, R.11
Medrano, A.P.12
Carroll, W.13
Marsh, K.14
Sullivan, J.P.15
Faltynek, C.R.16
Jarvis, M.F.17
-
55
-
-
34347349007
-
7 receptor antagonists ease the pain
-
7 receptor antagonists ease the pain. Br J Pharmacol 151: 565-567.
-
(2007)
Br J Pharmacol
, vol.151
, pp. 565-567
-
-
King, B.F.1
-
56
-
-
70350339068
-
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors
-
Donnelly-Roberts D, Namovic MT, Han P, Jarvis MF (2009) Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol 157: 1203-1214.
-
(2009)
Br J Pharmacol
, vol.157
, pp. 1203-1214
-
-
Donnelly-Roberts, D.1
Namovic, M.T.2
Han, P.3
Jarvis, M.F.4
-
57
-
-
84973118509
-
-
Accessed 1 June 2011
-
Jacobson (2010) P2X and P2Y receptors. http://www. tocris. com/pdfs/pdf_downloads/Purinergic_Receptors_Review. pdf. Accessed 1 June 2011.
-
(2010)
P2X and P2Y receptors
-
-
Jacobson, K.A.1
|